Clinical trials
Purpura, Thrombocytopenic, Idiopathic trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
49 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 2 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2012 | 1 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 5 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 5 |
| 2024 | 5 |
| 2025 | 8 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 26 |
| Recruiting | 12 |
| Terminated | 5 |
| Active, not recruiting | 4 |
| Enrolling by invitation | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 6 |
| argenx | 6 |
| Amgen | 4 |
| GlaxoSmithKline | 3 |
| Takeda | 3 |
| Chugai Pharmaceutical | 2 |
| Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | 2 |
| Rigel Pharmaceuticals | 2 |
| UCB Biopharma SRL | 2 |
| Alpine Immune Sciences Inc, A Subsidiary of Vertex | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Purpura, Thrombocytopenic, Idiopathic | 49 |
| Thrombocytopenia | 7 |
| Purpura | 6 |
| Autoimmune Diseases | 4 |
| Blood Platelet Disorders | 4 |
| Hematologic Diseases | 4 |
| Hemorrhage | 4 |
| Hemorrhagic Disorders | 4 |
| Immune System Diseases | 3 |
| Purpura, Thrombocytopenic | 3 |
Trials
Showing 1 to 25 of 49. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.